Janux Therapeutics (JANX) FCF Margin (2021 - 2026)
Janux Therapeutics' FCF Margin came in at 119.63% for Q2 2026, up 457.42 percentage points from the prior quarter.
Powered by 
Analysis
Janux Therapeutics (JANX) FCF Margin (2021 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Janux Therapeutics reported FCF Margin of -174.69%, up 13653.10 percentage points year-over-year; for FY2025, it came in at -832.78%, down 415.58 percentage points from FY2024.
- FCF Margin carries a four-year change of -325.27 percentage points (FY2021 to FY2025).
- Going back by year, FCF Margin was -417.20% in FY2024 (+231.38 pp), -648.58% in FY2023 (-75.35 pp), -573.24% in FY2022 (-65.73 pp) and -507.51% in FY2021.
- The Q2 2026 figure represents the highest quarterly FCF Margin since Q1 2021.
- The fastest year-over-year change in FCF Margin over five years came in Q2 2024 (a gain of 1365.39 percentage points), and the weakest in Q1 2022 (a drop of 2209.90 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn | 33.76% |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn | 28.82% |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn | 18.33% |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn | 26.96% |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | 38.60% |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | 6.55% |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn | 34.70% |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | 44.00% |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn | 2.01% |
| 10 | Janux Therapeutics | 1.09 Bn | -2.79 Bn | - | 119.63% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 119.63% |
| Mar 31, 2026 | -337.80% |
| Sep 30, 2025 | -129.49% |
| Sep 30, 2024 | -513.90% |
| Jun 30, 2024 | -113.70% |
| Mar 31, 2024 | -1,200.80% |
| Dec 31, 2023 | -423.24% |
| Sep 30, 2023 | -483.87% |
| Jun 30, 2023 | -1,479.09% |
| Mar 31, 2023 | -693.16% |
| Dec 31, 2022 | -491.00% |
| Sep 30, 2022 | -878.87% |
| Jun 30, 2022 | -294.76% |
| Mar 31, 2022 | -786.22% |
| Dec 31, 2021 | -721.16% |
| Sep 30, 2021 | -511.73% |
| Jun 30, 2021 | -1,303.53% |
| Mar 31, 2021 | 1,423.68% |
API Access
Janux Therapeutics FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=JANX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "JANX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=JANX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();